Cullinan Therapeutics
Arialle Weinstein, CPA, currently serves as Accounting Manager at Cullinan Therapeutics since May 2024, previously holding the same position at Inozyme Pharma from August 2021. Weinstein's extensive experience includes senior and associate roles with responsibilities in financial statement preparation, compliance with US GAAP, internal controls testing, and supporting audit processes for public filings such as 10-Q and 10-K. Key achievements include participation in Sarbanes-Oxley compliance efforts, collaboration with internal and external auditors, and leading implementation teams for contract management. Education includes a Bachelor of Science in Corporate Finance and Accounting from Bentley University, earned from 2014 to 2018.
This person is not in the org chart
This person is not in any teams
Cullinan Therapeutics
1 followers
Cullinan Therapeutics is dedicated to creating new standards of care for patients. We have strategically built a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Our portfolio encompasses a wide range of modalities, each with the potential to be best and/or first in class. Anchored in a deep understanding of oncology, immunology, and translational medicine, we create differentiated ideas, identify the most appropriate targets, and select the optimal modality to develop transformative therapeutics across a wide variety of cancer and autoimmune indications.